Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$412M |
| 2 |
Advanced Micro Devices
AMD
|
+$294M |
| 3 |
Apple
AAPL
|
+$244M |
| 4 |
Qualcomm
QCOM
|
+$207M |
| 5 |
Pinduoduo
PDD
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$510M |
| 2 |
Uber
UBER
|
+$419M |
| 3 |
Chevron
CVX
|
+$286M |
| 4 |
Meta Platforms (Facebook)
META
|
+$255M |
| 5 |
NVO
Novo Nordisk
NVO
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.64% |
| 2 | Healthcare | 18.28% |
| 3 | Consumer Discretionary | 13.73% |
| 4 | Industrials | 8.65% |
| 5 | Financials | 7.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DFSV
1901
Dimensional US Small Cap Value ETF
DFSV
$8.45B
| $1.95M | ﹤0.01% |
67,900
+27,700
| +69% | +$804K |
|
|
SMLR
1902
DELISTED
Semler Scientific
SMLR
| $1.95M | ﹤0.01% |
56,800
-24,600
| -30% | -$709K |
|
1903
Acco Brands
ACCO
$399M
| $1.94M | ﹤0.01% |
413,500
+91,600
| +28% | +$457K |
|
1904
Benchmark Electronics
BHE
$2.94B
| $1.94M | ﹤0.01% |
49,100
-8,300
| -14% | -$305K |
|
1905
Scholastic
SCHL
$784M
| $1.94M | ﹤0.01% |
+54,577
| New | +$1.95M |
|
1906
Saga Communications
SGA
$64.6M
| $1.93M | ﹤0.01% |
122,744
+6,800
| +6% | +$136K |
|
1907
Omega Flex
OFLX
$304M
| $1.93M | ﹤0.01% |
37,695
+11,515
| +44% | +$735K |
|
|
ZUO
1908
DELISTED
Zuora, Inc.
ZUO
| $1.93M | ﹤0.01% |
194,400
-29,800
| -13% | -$287K |
|
1909
Domo
DOMO
$184M
| $1.93M | ﹤0.01% |
249,700
-69,200
| -22% | -$517K |
|
1910
CVB Financial
CVBF
$4.05B
| $1.93M | ﹤0.01% |
111,694
+65,800
| +143% | +$1.1M |
|
1911
Neurogene
NGNE
$740M
| $1.92M | ﹤0.01% |
52,807
-5,900
| -10% | -$208K |
|
1912
Pulmonx
LUNG
$98.4M
| $1.91M | ﹤0.01% |
301,410
+34,800
| +13% | +$268K |
|
1913
Titan Machinery
TITN
$431M
| $1.9M | ﹤0.01% |
119,800
-6,700
| -5% | -$140K |
|
1914
Arcosa
ACA
$7.12B
| $1.9M | ﹤0.01% |
+22,800
| New | +$1.9M |
|
1915
Sibanye-Stillwater
SBSW
$7.58B
| $1.9M | ﹤0.01% |
436,935
+242,735
| +125% | +$1.2M |
|
1916
iShares Core S&P Mid-Cap ETF
IJH
$128B
| $1.9M | ﹤0.01% |
+32,400
| New | +$1.9M |
|
1917
-1x Short VIX Futures ETF
SVIX
$171M
| $1.88M | ﹤0.01% |
39,500
+31,200
| +376% | +$1.35M |
|
1918
Mirion Technologies
MIR
$3.79B
| $1.87M | ﹤0.01% |
174,000
-128,500
| -42% | -$1.37M |
|
1919
Precigen
PGEN
$2.45B
| $1.87M | ﹤0.01% |
1,182,690
+130,500
| +12% | +$189K |
|
1920
Vivid Seats
SEAT
$81.6M
| $1.86M | ﹤0.01% |
16,211
+10,491
| +183% | +$1.14M |
|
1921
Seacoast Banking Corp of Florida
SBCF
$3.44B
| $1.86M | ﹤0.01% |
78,605
+35,700
| +83% | +$833K |
|
1922
Huntsman Corp
HUN
$1.78B
| $1.85M | ﹤0.01% |
81,400
-415,700
| -84% | -$10.1M |
|
1923
Kingstone Companies
KINS
$284M
| $1.85M | ﹤0.01% |
369,389
+19,201
| +5% | +$87.6K |
|
|
FBCG
1924
Fidelity Blue Chip Growth ETF
FBCG
$7.34B
| $1.85M | ﹤0.01% |
+43,500
| New | +$1.72M |
|
1925
Atossa Therapeutics
ATOS
$23.5M
| $1.85M | ﹤0.01% |
103,394
+10,969
| +12% | +$243K |
|
Similar funds
Jim Simons's Q2 2024 Portfolio in Review
As of Q2 2024, Jim Simons held 4,123 positions worth $59B, down 7.3% from $63.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons withdrew a net $4.49B in Q2 2024, closing 674 positions and reducing 1,503 holdings. Its most notable exit was Bank of America, an estimated $142M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Jim Simons opened a new position in Broadcom worth $472M.
- Jim Simons's largest Q2 2024 buy was Broadcom: 2,941,150 shares worth $472M.
- Jim Simons added most to Apple in Q2 2024, an estimated $244M increase.
- Jim Simons's biggest Q2 2024 reduction was Amazon, cutting an estimated $510M.
- Jim Simons fully exited Bank of America in Q2 2024, selling an estimated $142M.
- Jim Simons's ten largest holdings make up 12% of its $59B portfolio in Q2 2024.
- Jim Simons opened 463 new positions and closed 674 in Q2 2024.
- Jim Simons's portfolio value fell 7.3% quarter-over-quarter to $59B.
Based on Renaissance Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.